Company Description

Entrada Therapeutics is a biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines, Endosomal Escape Vehicle (EEV) therapeutics, to engage intracellular targets that have long been considered inaccessible and undruggable.